Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer-Reference-Cited by-同舟云学术

Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer

Published:2019-09 Issue:8 Volume:30 Page:866-872
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Luo Yang,Li Wei,Jiang Zefei,Zhang Qingyuan,Wang Liwei,Mao Yixiang,Tjan-Heijnen Vivianne C.G.,Im Seock-Ah,McConnell Robin,Bejarano Sara,Fumagalli Debora,Bines José,Wang Bei,Garg Amit,Kirschbrown Whitney P.,Xu Binghe

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference17 articles.

1. Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models.;Scheuer;Cancer Res,2009

2. A new anti-ErbB2 strategy in the treatment of cancer: prevention of ligand-dependent ErbB2 receptor heterodimerization.;Baselga;Cancer Cell,2002

3. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.;Franklin;Cancer Cell,2004

4. Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.;Baselga;N Engl J Med,2012

5. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.;Swain;N Engl J Med,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ex vivo dual gene therapy using human adipocytes secreting anti-HER2 antibody on HER2-positive xenograft tumor models;Breast Cancer;2023-08-23

2. Targeted Nanoparticle for Co‐delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis;Small;2022-01-27

3. Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVASTEM Trial;Cancers;2021-01-05

4. A computational diffusion model to study antibody transport within reconstructed tumor microenvironments;BMC Bioinformatics;2020-11-17